Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin
Berenguer M. Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin. J Hepatol 49 (2008) 274
Impact of donor age on the results of liver transplantation in hepatitis C virus-positive recipients
Pérez-Daga J.A., Ramirez-Plaza C., Suárez M.A., et al. Impact of donor age on the results of liver transplantation in hepatitis C virus-positive recipients. Transplant Proc 40 (2008) 2959
Treatment for recurrent hepatitis C virus infection after liver transplantation
Balbi E., Leal C.R.G., Pacheco-Moreira L.F., et al. Treatment for recurrent hepatitis C virus infection after liver transplantation. Transplant Proc 41 (2009) 891
Efficacy, predictor of response, and potential risks associated with antiviral therapy in liver transplant with recurrent hepatitis C
Berenguer M., Palau A., Fernández A., et al. Efficacy, predictor of response, and potential risks associated with antiviral therapy in liver transplant with recurrent hepatitis C. Liver Transpl 12 (2006) 1067
Clinical and histological efficacy of pegylated interferon and ribavirin therapy on recurrent hepatitis C after liver transplantation
Fernandez I., Meneu J.C., Colina F., et al. Clinical and histological efficacy of pegylated interferon and ribavirin therapy on recurrent hepatitis C after liver transplantation. Liver Transpl 12 (2006) 1805
Efficacy of antiviral therapy on hepatitis C after liver transplantation: a randomized controlled study
Carrión J.A., Navasa M., Garcia-Retortillo M., et al. Efficacy of antiviral therapy on hepatitis C after liver transplantation: a randomized controlled study. Gastroenterology 132 (2007) 1746
Sustained viral response to therapy of recurrent hepatitis C after liver transplantation is related to early viral response and dose adherence
Sharma P., Marrero J.A., Fontana R.J., et al. Sustained viral response to therapy of recurrent hepatitis C after liver transplantation is related to early viral response and dose adherence. Liver Transpl 13 (2007) 1100
Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon alpha-2b and ribavirin: an open-label series
Rodriguez-Luna H., Khatib A., Sharma P., et al. Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon alpha-2b and ribavirin: an open-label series. Transplantation 77 (2004) 190
Hepatitis C recurrence after liver transplantation: viral and histologic response to full-dose peg-interferon and ribavirin
Oton E., Barcena R., Moreno-Planas, et al. Hepatitis C recurrence after liver transplantation: viral and histologic response to full-dose peg-interferon and ribavirin. Am J Transplant 6 (2006) 2348